2009Acta Academiae Medicinae WannanRequires access

Plasma ET-1and NO level changes in pulmonary hypertensive rat models induced by monocrotaline

Yongfang Liu

Open publisher page 0 citations

Abstract

Objective:To determine the level changes of plasma endothelin 1(ET-1)and NO in the rat models with pulmonary hypertension induced by monocrotaline(MCT).Methods:Twenty adult male SD rats were randomized into normal controls(n=10)and MCT models(n=10).The pulmonary hypertensive animal models were established by intraperitoneal injection of MCT.Radioimmunoassay and chlormetric analysis were used to detect the plasma level of ET-1 and NO,respectively.Results:Three weeks after the injection of MCT,the mean pulmonary pressure was(18.13±4.33)mmHg in the controls and(31.65±8.52)mmHg in the models(P0.01).ET-1 plasma level was increased significantly(61.08±9.46 vs 95.92±15.78)while NO level was declined(115.32±27.15 vs 52.24±8.71)(P0.01).Conclusion:The potential mechanism of pulmonary hypertension induced by MCT suggests that ET-1 and NO content may be involved in the modified active compounds in the plasma.

About this research paper

What this paper is about

Objective:To determine the level changes of plasma endothelin 1(ET-1)and NO in the rat models with pulmonary hypertension induced by monocrotaline(MCT).Methods:Twenty adult male SD rats were randomized into normal controls(n=10)and MCT models(n=10).The pulmonary hypertensive animal models were established by intraperitoneal injection of MCT.Radioimmunoassay and chlormetric analysis were used to detect the plasma level of ET-1 and NO,respectively.Results:Three weeks after the injection of MCT,the mean pulmonary pressure was(18.13±4.33)mmHg in the controls and(31.65±8.52)mmHg in the models(P0.01).ET-1 plasma level was increased significantly(61.08±9.46 vs 95.92±15.78)while NO level was declined(115.32±27.15 vs 52.24±8.71)(P0.01).Conclusion:The potential mechanism of pulmonary hypertension induced by MCT suggests that ET-1 and NO content may be involved in the modified active compounds in the plasma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To determine the level changes of plasma endothelin 1(ET-1)and NO in the rat models with pulmonary hypertension induced by monocrotaline(MCT).Methods:Twenty adult male SD rats were randomized into normal controls(n=10)and MCT models(n=10).The pulmonary hypertensive animal models were established by intraperitoneal injection of MCT.Radioimmunoassay and chlormetric analysis were used to detect the plasma level of ET-1 and NO,respectively.Results:Three weeks after the injection of MCT,the mean pulmonary pressure was(18.13±4.33)mmHg in the controls and(31.65±8.52)mmHg in the models(P0.01).ET-1 plasma level was increased significantly(61.08±9.46 vs 95.92±15.78)while NO level was declined(115.32±27.15 vs 52.24±8.71)(P0.01).Conclusion:The potential mechanism of pulmonary hypertension induced by MCT suggests that ET-1 and NO content may be involved in the modified active compounds in the plasma.

Key concepts: Pulmonary hypertension, Medicine, Internal medicine, Radioimmunoassay, Endothelin 1, Endocrinology, Animal model, Plasma levels

Related papers

Back to paper searchBrowse research topicsOriginal source
Plasma ET-1and NO level changes in pulmonary hypertensive rat models induced by monocrotaline — Research Paper | ScholarLens